Company page

Biocryst Pharmaceuticals, Inc.

Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in America with a market capitalization of approximately $2.26 billion. The company focuses on developing innovative therapies for rare diseases. Biocryst is committed to advancing its pipeline of treatments to improve patient outcomes.